top
Search terms
Results 1 - 9 of 9 - ordered by :
Ejhf

Effect of eplerenone in percutaneous coronary intervention‐treated post‐myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS ...

European Journal of Heart Failure, Iqbal, Javaid, Fay, Renaud, Adlam, David, Squire, Iain, Parviz, Yasir, Gunn, Julian, Pitt, Bertram, Zannad, Faiez

Date : 01/06/2014 Item size : 155845 bytes
Ejhf

Tel: +1 419 383 3697, Fax: +1 419 383 3041, Email: george.moukarbel@utoledo.edu Search for more papers by this author Zi-Fan Yu, Statistics Collaborative, Inc., Washington, DC, USASearch for more ...

European Journal of Heart Failure, Moukarbel, George V., Yu, Zi‐Fan, Dickstein, Kenneth, Hou, Yingxin (Rachel), Wittes, Janet T., McMurray, John J. V., Pitt, Bertram, Zannad, Faiez, Pfeffer, Marc ...

Date : 01/03/2014 Item size : 197654 bytes
Ejhf

Effect of eplerenone in percutaneous coronary intervention‐treated post‐myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS ...

European Journal of Heart Failure, Iqbal, Javaid, Fay, Renaud, Adlam, David, Squire, Iain, Parviz, Yasir, Gunn, Julian, Pitt, Bertram, Zannad, Faiez

Date : 01/06/2014 Item size : 157879 bytes
Ehjournal

Improvement in glycaemic control is no longer an acceptable surrogate for efficacy (or safety) with regard to cardiovascular outcomes.35 Safety must be formally demonstrated in adequately powered ...

European Heart Journal, Zannad, Faiez, Stough, Wendy Gattis, Pocock, Stuart J., Sleight, Peter, Cushman, William C, Cleland, John G.F., McMurray, John J.V., Lonn, Eva, Geller, Nancy L., Wedel, Hans, ...

Date : 01/05/2012 Item size : 369253 bytes
Ehjournal

[...]at approval, the relation between non-cardiovascular benefit and cardiovascular risk may not be adequately defined. Deficiencies of pre-approval data are exemplified by issues emerging from the ...

European Heart Journal, Borer, Jeffrey S., Pouleur, Hubert, Abadie, Eric, Follath, Ferrenc, Wittes, Janet, Pfeffer, Marc A., Pitt, Bertram, Zannad, Faiez

Date : 01/08/2007 Item size : 216749 bytes
Ehjournal

Improvement in glycaemic control is no longer an acceptable surrogate for efficacy (or safety) with regard to cardiovascular outcomes.35 Safety must be formally demonstrated in adequately powered ...

European Heart Journal, Zannad, Faiez, Stough, Wendy Gattis, Pocock, Stuart J., Sleight, Peter, Cushman, William C, Cleland, John G.F., McMurray, John J.V., Lonn, Eva, Geller, Nancy L., Wedel, Hans, ...

Date : 01/05/2012
Ehjournal

[...]at approval, the relation between non-cardiovascular benefit and cardiovascular risk may not be adequately defined. Deficiencies of pre-approval data are exemplified by issues emerging from the ...

European Heart Journal, Borer, Jeffrey S., Pouleur, Hubert, Abadie, Eric, Follath, Ferrenc, Wittes, Janet, Pfeffer, Marc A., Pitt, Bertram, Zannad, Faiez

Date : 01/08/2007
Ejhf

[11] From a prognostic point of view, asymptomatic pulmonary congestion assessed by lung ultrasound is a well-established predictive factor in dialytic patients, and its detection can add significant ...

European Journal of Heart Failure, Coiro, Stefano, Rossignol, Patrick, Ambrosio, Giuseppe, Carluccio, Erberto, Alunni, Gianfranco, Murrone, Adriano, Tritto, Isabella, Zannad, Faiez, Girerd, Nicolas

Date : 01/11/2015 Item size : 203753 bytes
Ejhf

Tel: +1 419 383 3697, Fax: +1 419 383 3041, Email: george.moukarbel@utoledo.edu Search for more papers by this author Zi-Fan Yu, Statistics Collaborative, Inc., Washington, DC, USASearch for more ...

European Journal of Heart Failure, Moukarbel, George V., Yu, Zi‐Fan, Dickstein, Kenneth, Hou, Yingxin (Rachel), Wittes, Janet T., McMurray, John J. V., Pitt, Bertram, Zannad, Faiez, Pfeffer, Marc ...

Date : 01/03/2014 Item size : 206469 bytes